This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
A Final look - Sickle Cell Update | New gene editing data from EHA 2022
Ticker(s): CRSP, VRTXWho's the expert?
Institution: Duke
- Assistant Professor in Medicine and Pediatrics and Director of Clinical Research in Benign Hematology.
- Manages ~150 pediatric and 200 adult patients with sickle cell disease and 10 patients with beta thalassemia.
- Director of Duke’s sickle cell transition program where he has led multiple trials in sickle cell disease and is 75% research focused.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
